These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 3800542

  • 1. [Immunological studies on colorectal cancer].
    Funamoto M.
    Nihon Geka Hokan; 1986 May 01; 55(3):442-51. PubMed ID: 3800542
    [No Abstract] [Full Text] [Related]

  • 2. Lymphocyte subsets, natural killer cytotoxicity, and perioperative blood transfusion for elective colorectal cancer surgery.
    Tartter PI, Martinelli G.
    Cancer Detect Prev Suppl; 1987 May 01; 1():571-6. PubMed ID: 3480069
    [Abstract] [Full Text] [Related]

  • 3. [The natural killer blood count in patients with breast, colon and rectal cancers].
    Dryzhak VI, Iaremenko AV, Khramtsova NS.
    Vopr Onkol; 1989 May 01; 35(5):585-9. PubMed ID: 2741429
    [Abstract] [Full Text] [Related]

  • 4. [Antibody-dependent cell-mediated cytotoxicity (ADCC) in gastric and colorectal cancer].
    Sekizuka H, Noro K, Haruyama S, Kiribuchi Y, Hayashi F.
    Gan No Rinsho; 1986 Jul 01; 32(8):879-82. PubMed ID: 3747148
    [Abstract] [Full Text] [Related]

  • 5. Changes in peripheral T-cell subsets and natural-killer cytotoxicity in relation to colorectal cancer surgery.
    Tartter PI, Martinelli G, Steinberg B, Barron D.
    Cancer Detect Prev; 1986 Jul 01; 9(3-4):359-64. PubMed ID: 3488807
    [Abstract] [Full Text] [Related]

  • 6. [Preliminary study of the role of natural killer cells in human tumor immunity].
    Yin XY, Yuan DD.
    Zhonghua Bing Li Xue Za Zhi; 1986 Sep 01; 15(3):179-82. PubMed ID: 2953453
    [No Abstract] [Full Text] [Related]

  • 7. [Suppression of immunological response by ascitic fluid from gastrointestinal cancer patients].
    Amemiya K.
    Nihon Geka Gakkai Zasshi; 1983 Dec 01; 84(12):1229-36. PubMed ID: 6201709
    [Abstract] [Full Text] [Related]

  • 8. [Colorectal neoplasms: preoperative determination of GICA].
    Bussone R, Sanlorenzo M, Natta F, Rocca N, Caldarola B.
    Minerva Chir; 1987 Oct 31; 42(20):1655-6. PubMed ID: 3479706
    [No Abstract] [Full Text] [Related]

  • 9. [Influence of extirpative surgery on the natural killer cell activity in peripheral blood in cancer patients].
    Wang H.
    Zhonghua Wai Ke Za Zhi; 1990 Oct 31; 28(10):622-4, 638. PubMed ID: 2086059
    [Abstract] [Full Text] [Related]

  • 10. [Preoperative determination of serum immunoglobulins in colorectal cancer: correlation between staging and course of the disease].
    Secco GB, Frassetto GL, Venturini M, Santi F, Fardelli R, Terrizzi A.
    Minerva Dietol Gastroenterol; 1986 Oct 31; 32(2):183-6. PubMed ID: 3736967
    [No Abstract] [Full Text] [Related]

  • 11. Immunological aspects of colorectal cancer.
    Sjögren HO.
    Clin Gastroenterol; 1976 Sep 31; 5(3):563-71. PubMed ID: 1032988
    [No Abstract] [Full Text] [Related]

  • 12. [Immunological changes in patients with colorectal cancer].
    Gürcüoğlu I, Ozbal Y, AritaşY.
    Mikrobiyol Bul; 1984 Jan 31; 18(1):37-46. PubMed ID: 6611476
    [Abstract] [Full Text] [Related]

  • 13. The in vitro migration inhibition of mononuclear cells in patients with colorectal carcinoma.
    Kowalczyk D, Zembala M, Popiela T, Labza H.
    Arch Immunol Ther Exp (Warsz); 1978 Jan 31; 26(1-6):435-9. PubMed ID: 749793
    [Abstract] [Full Text] [Related]

  • 14. Alterations in circulating lymphocyte number and function after circulation through colorectal carcinomas.
    Rigg KM, Shenton BK, Brotherick I, Taylor RM, Lennard TW.
    Surgery; 1991 Jun 31; 109(6):747-55. PubMed ID: 2042094
    [Abstract] [Full Text] [Related]

  • 15. [Follow-up of colorectal neoplasms: use of TPA].
    Citone G, Catani M, Procacciante F, Perri S, Pronio A, Ribotta G.
    Minerva Chir; 1987 Oct 31; 42(20):1625-6. PubMed ID: 3683924
    [No Abstract] [Full Text] [Related]

  • 16. NK cells, IBD, and cancer.
    Gibson PR.
    Gastroenterology; 1986 May 31; 90(5 Pt 1):1314-5. PubMed ID: 3956953
    [No Abstract] [Full Text] [Related]

  • 17. Effects of a preoperative course of interleukin-2 on surgical and immunobiological variables in patients with colorectal cancer: a phase 2 study.
    Brivio F, Lissoni P, Barni S, Tancini G, Ardizzoia A, Erba L, Alderi G, Nociti V.
    Eur J Surg; 1993 Jan 31; 159(1):43-7. PubMed ID: 8095806
    [Abstract] [Full Text] [Related]

  • 18. [Carcinoembryonic antigen measurement used routinely in the control of patients subjected to surgical treatment for colorectal cancer].
    Werner C, Nielsen J, Sparsø BH.
    Ugeskr Laeger; 1988 Feb 15; 150(7):426-8. PubMed ID: 3381354
    [No Abstract] [Full Text] [Related]

  • 19. Carcinoembryonic antigen in the diagnosis and follow-up of colorectal carcinoma.
    Kåresen R, Hertzberg J, Johannesen J, Thoresen BO, Orjasaeter H.
    Am J Proctol Gastroenterol Colon Rectal Surg; 1980 Nov 15; 31(11):18-22. PubMed ID: 7212050
    [No Abstract] [Full Text] [Related]

  • 20. [The relationship between selenium and immunity in large bowel cancer].
    Yu B, Wang M, Li D.
    Zhonghua Wai Ke Za Zhi; 1996 Jan 15; 34(1):50-3. PubMed ID: 9275690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.